Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy
Crossref DOI link: https://doi.org/10.1186/s13058-016-0679-3
Published Online: 2016-02-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kasimir-Bauer, Sabine
Bittner, Ann-Kathrin
König, Lisa
Reiter, Katharina
Keller, Thomas
Kimmig, Rainer
Hoffmann, Oliver
License valid from 2016-02-12